Biopharmaceuticals
Generics
Oncology
Regulatory
News Release - October 19, 2018
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
Source: Mylan
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.